To compare the effectiveness of 3 × 3 mm versus 6 × 6 mm swept source optical coherence tomography angiography (SS-OCTA) scan patterns in detecting and characterizing pachychoroid-associated macular neovascularization (MNV).
Methods
We retrospectively analyzed 79 eyes from 79 treatment-naïve patients with pachychoroid-associated MNV using SS-OCTA. Both 3 × 3 mm and 6 × 6 mm scans were obtained on the same day. Two masked graders independently evaluated neovascular network area and presence of anastomoses.
Results
Mean lesion areas were significantly larger in 6 × 6 mm scans compared to 3 × 3 mm scans (0.869 ± 0.868 mm² vs 0.699 ± 0.697 mm²; p = 0.005). However, analysis of anastomoses revealed superior detection with 3 × 3 mm scans, with 12 eyes (15.2%) showing anastomoses only in 3 × 3 mm scans compared to 4 eyes (5.1%) visible only in 6 × 6 mm scans (p = 0.021). Interobserver agreement was excellent for area measurements (ICC = 0.92).
Conclusions
While 6 × 6 mm SS-OCTA scans demonstrate larger overall neovascular area measurements, the 3 × 3 mm scan pattern provides superior visualization of anastomoses and fine vascular details in pachychoroid-associated MNV. These findings suggest that 3 × 3 mm scans should be considered the preferred protocol for detailed evaluation of these lesions.
YanıkÖDemirelSÖzcanG, et al.Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography. Eye (Basingstoke)2024; 38: 1714–1721. doi:10.1038/s41433-024-03007-2
2.
MastropasquaREvangelistaFAmodeiF, et al.Optical coherence tomography angiography in macular neovascularization: a comparison between different octa devices. Transl Vis Sci Technol2020; 9: 1–7. doi:10.1167/TVST.9.11.6
3.
ViggianoPDemirelSPetruzzellaG, et al.Choriocapillaris flow in two different patterns of exudative type 1 macular neovascularization. Eye (Lond)2025; 39: 556–562. doi:10.1038/S41433-024-03587-Z
4.
BorrelliEBattistaMGelorminiF, et al.Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease. Sci Rep2020; 10: 1–7. doi:10.1038/s41598-020-77566-1
5.
TsaiWSThottarathSGurudasS, et al.A comparison of optical coherence tomography angiography metrics and artifacts on scans of different sizes in diabetic macular ischemia. Am J Ophthalmol2025; 269: 303–314. doi:10.1016/J.AJO.2024.09.012
6.
XiaoBSongYYanM, et al.Quantitative analysis of choroidal vascular structures and anatomical changes in pachychoroid spectrum diseases using ultra-widefield SS-OCTA. Sci Rep2025; 15: 344. doi: 10.1038/S41598-024-82745-5
7.
KiilgaardHCNissenAHKBalaratnasingamC, et al.Diagnostic accuracy of OCT angiography for macular neovascularization in central serous chorioretinopathy: A systematic review and meta-analysis. Acta Ophthalmol2024; 102: 749–758. doi: 10.1111/aos.16739
8.
ChoiMAhnSYunC, et al.Quantitative OCT angiography findings according to pattern classification of type 1 neovascularization exudative age-related macular degeneration. Eye2021; 36: 414–423. doi:10.1038/S41433-021-01496-Z
9.
ViggianoPMiereABorrelliE, et al.The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD . Invest Ophthalmol Vis Sci2023; 64: 32. doi: 10.1167/IOVS.64.14.32
10.
ViggianoPLandiniLGrassiMO, et al.Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization. Sci Rep2023; 13: 16337. doi:10.1038/S41598-023-43635-4
11.
ViggianoPGrassiMOPignataroM, et al.Topographical analysis of the choriocapillaris reperfusion after loading anti-VEGF therapy in neovascular AMD. Transl Vis Sci Technol2022; 11: 18. doi:10.1167/TVST.11.9.18
12.
ViggianoPCostanzoEGianniniD, et al.In vivo assessment of associations between photoreceptors structure and macular perfusion in type 1 diabetes. Br J Ophthalmol2022; 107: 1672–1679. doi:10.1136/BJO-2022-321617
13.
FaatzHRothausKZieglerM, et al.Quantitative comparison of the vascular structure of macular neovascularizations between swept-source and spectral-domain optical coherence tomography angiography. Clin Ophthalmol2020; 14: 3179–3186. doi:10.2147/OPTH.S276114
14.
FaatzHRothausKZieglerM, et al.Vascular analysis of type 1, 2, and 3 macular neovascularization in age-related macular degeneration using swept-source optical coherence tomography angiography shows new insights into differences of pathologic vasculature and may lead to a more personalized understanding. Biomedicines2022; 10: 694.
15.
FaatzHRothausKZieglerM, et al.The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD. Diagnostics (Basel)2022; 12: 2807.
16.
MiyakeMOotoSYamashiroK, et al.Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep2015; 6: 5.
17.
BiçerÖDemirelSYavuzZ, et al.Comparison of morphological features of type 1 CNV in AMD and pachychoroid neovasculopathy: an OCTA study. Ophthalmic Surg Lasers Imaging Retina2020; 51: 640–647.
18.
KuranamiAMarukoRMarukoI, et al.Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration. Sci Rep2023; 13: 7379.
19.
AltinisikMKurtESonmezerP, et al.A comparative study of type 1 neovascularization: neovascular age-related macular degeneration versus pachychoroid neovasculopathy. Eur J Ophthalmol2022; 32: 2404–2411.
20.
SuYZhangXGanY, et al.Detection of pachychoroid neovasculopathy with optical coherence tomography angiography versus dye angiography imaging. Photodiagnosis Photodyn Ther2022; 40: 103126.
21.
AzarGWolffBMauget-FaÿsseM, et al.Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Acta Ophthalmol2017; 95: 421–427.
22.
ArfSSayman MuslubasIHocaogluM, et al.Features of neovascularization in pachychoroid neovasculopathy compared with type 1 neovascular age-related macular degeneration on optical coherence tomography angiography. Jpn J Ophthalmol2020; 64: 257–264.
23.
ViggianoPBosciaGSadeghiE, et al.Pachychoroid disease spectrum: how multimodal imaging and OCT angiography have improved our knowledge. Prog Retin Eye Res2025; 107: 101372.
24.
TotoLRuggeriMLEvangelistaF, et al.Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy. Eye (Lond)2022; 37: 1214–1218.
25.
ViggianoPMoscaraFTermiteAC, et al.Choroidal layer analysis under flat irregular pigment epithelial detachments in central serous chorioretinopathy. Am J Ophthalmol2025; 276: 210–217.
26.
CheungCMGDansinganiKKKoizumiH, et al.Pachychoroid disease: review and update. Eye2024; 39: 819–834.
HataMYamashiroKOotoS, et al.Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Investigative Opthalmology & Visual Science2017; 58: 292.
29.
KatoYOguchiYOmoriT, et al.Complement activation products and cytokines in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci2020; 61: 39.
30.
ViggianoPTermiteACBosciaG, et al.Photoreceptor damage in pachychoroid pigment epitheliopathy. Eye (Basingstoke)2025; 1: 21.
31.
AhmedMSyrineBMNadiaBA, et al.Optical coherence tomography angiography features of macular neovascularization in wet age-related macular degeneration: a cross-sectional study. Ann Med Surg (Lond)2021; 70: 102826.
